Filing Flows › Tango Therapeutics (TNGX) › Stock forecast & fair value
Tango Therapeutics (TNGX) stock forecast and price target
Tango Therapeutics (TNGX) trades at $21.50. 11 analysts' median price target is $46.00 (+114%), from $24.00 to $69.00.
Tango Therapeutics' latest quarter
Tango Therapeutics, Q3 2025: revenue $53.8M (+364% year over year), operating margin 26.2%, net earnings $15.9M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for TNGX stock?
The median of 11 analysts' 12-month targets is $46.00, +114% from $21.50; the range is $24.00 to $69.00. The average rating is strong buy.
Does Tango Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is TNGX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.